ADVERTISEMENT RETURN TO ISSUEPREVPerspectiveNEXTGlucagon-like Peptide-1: The Basis of a New Class of Treatment for Type 2 DiabetesLotte Bjerre KnudsenView Author Information Discovery Biology Management, Novo Nordisk, DK-2760 Maaloev, Denmark Cite this: J. Med. Chem. 2004, 47, 17, 4128–4134Publication Date (Web):July 20, 2004Publication History Received24 December 2003Published online20 July 2004Published inissue 1 August 2004https://pubs.acs.org/doi/10.1021/jm030630mhttps://doi.org/10.1021/jm030630mreview-articleACS PublicationsCopyright © 2004 American Chemical SocietyRequest reuse permissionsArticle Views2460Altmetric-Citations135LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstract
No takes yet. Share an insight, caveat, or question.
Lotte Bjerre Knudsen (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: